glutathione and triple negative breast cancer Ferroptosis heterogeneity in triple-negative reveals an innovative immunotherapy combination strategy Ferroptosis heterogeneity in triple-negative breast
Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy: Cell Metabolism Comprehensive single cell metabolic profiling identifies targets to sensitize triple negative breast cancer to chemo immunotherapy: Cell Reports Medicine Frontiers Oxidative stress and antioxidants in breast cancer: a double edged sword CD36 enhances sensitivity of triple negative breast cancer cells to palmitate induced ferroptosis Cell Death & Disease
Pay in 4 interest-free payments of $6.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



